Metabolic drug-drug interactions: perspective from FDA medical and clinical pharmacology reviewers.
Balian
J D
JD
Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland 20857, USA.
Rahman
A
A
D017277:Drug Approval; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D006801:Humans; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations